Testimony from the Bedside: From Coley's Toxins to Targeted Immunotherapy

Cancer Cell

Volumn 18, Issue 1, 2010, Pages 9-10

  Park, Jin Mo ^a   Fisher, David E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; B RAF KINASE; CANCER VACCINE; GLYCOPROTEIN GP 100; IPILIMUMAB; STEROID; TUMOR NECROSIS FACTOR INHIBITOR;

CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CELLULAR IMMUNITY; CLINICAL TRIAL; COLITIS; DRUG EFFICACY; GENE MUTATION; HUMAN; IMMUNE RESPONSE; MELANOMA; METASTASIS; NONHUMAN; ONCOGENE C KIT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RASH; SHORT SURVEY;

EID: 77954249068     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2010.06.010     Document Type: Short Survey

References (9)

1. Boni A., Cogdill A.P., Dang P., Udayakumar D., Njauw C.N., Sloss C.M., Ferrone C.R., Flaherty K.T., Lawrence D.P., Fisher D.E., et al. Cancer Res. 2010, in press. Published online June 15, 2010. 10.1158/0008-5472.CAN-10-0118.
2. Coley W. Am. J. Med. Sci. 1893, 105:487-510.
3. Fong L., Small E.J. J. Clin. Oncol. 2008, 26:5275-5283.
4. Hodi F.S., O'Day S.J., McDermott D.F., Weber R.W., Sosman J.A., Haanen J.B., Gonzalez R., Robert C., Schadendorf D., Hassel J.C., et al. N. Engl. J. Med. 2010, in press. Published online June 14, 2010. 10.1056/NEJMoa1003466.
5. Jain N., Nguyen H., Chambers C., Kang J. Proc. Natl. Acad. Sci. USA 2010, 107:1524-1528.
6. Leach D.R., Krummel M.F., Allison J.P. Science 1996, 271:1734-1736.
7. Peggs K.S., Quezada S.A., Chambers C.A., Korman A.J., Allison J.P. J. Exp. Med. 2009, 206:1717-1725.
8. Teft W.A., Kirchhof M.G., Madrenas J. Annu. Rev. Immunol. 2006, 24:65-97.
9. Wing K., Onishi Y., Prieto-Martin P., Yamaguchi T., Miyara M., Fehervari Z., Nomura T., Sakaguchi S. Science 2008, 322:271-275.